Central African Republic vs Gabon: Average non-HDL cholesterol levels
Central African Republic
2.8
in 2018
Gabon
2.8
in 2018
Central African Republic rank
163rd
Gabon rank
163rd
Average non-HDL cholesterol levels over time
- Central African Republic
- Gabon
How they compare
Central African Republic currently reports 2.8 against 2.8 in Gabon, a difference of 0.
Across all 39 years both countries report, Gabon has been ahead every year.
Central African Republic ranks 163rd and Gabon ranks 163rd of 191 countries.
Gabon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Central African Republic | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.67 | 2.98 | 0.31 | Gabon |
| 1990s | 2.7 | 3.1 | 0.4 | Gabon |
| 2000s | 2.78 | 3 | 0.22 | Gabon |
| 2010s | 2.8 | 2.89 | 0.0889 | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Central African Republic or Gabon?
- Central African Republic, at 2.8 against 2.8 in Gabon as of 2018.
- What is the difference in average non-hdl cholesterol levels between Central African Republic and Gabon?
- 0, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Gabon?
- 39 years are reported by both, from 1980 to 2018.
- How do Central African Republic and Gabon rank globally for average non-hdl cholesterol levels?
- Central African Republic ranks 163rd and Gabon ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.